China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap11.4B
Enterprise Value11.16B
P/E Ratio-155,400
PEG Ratio1,553.8
Price/Sales Ratio4.25
Price/Book Ratio1.05
Enterprise/Revenue3.92
Enterprise/EBITDA115.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0
Operating Margin-0.06
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue2.05B
Revenue/Share3.66
Gross Profit936.88M
EBITDA270.13M
Net Income112.7M
Diluted EPS0.22

Balance Sheet

Total Cash2.77B
Total Cash/Share5.49
Total Debt219.03M
Total Debt/Equity0.03
Current Ratio6.32
Book Value Per Share14.8

Price History

52-Week Change-39.34
52-Week High27.99
52-Week Low14.78
Moving Average 50 Days17.06
Moving Average 200 Days21.53

Statistics

Average Volume7.04M
Shares Outstanding504.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.22
Trailing Annual Dividend Yield1.44
Payout Ratio45.59
Last Split Factor3:2
Last Split DateMay 26, 2017
AD